| Literature DB >> 21300093 |
Ashlesh K Murthy1, Weidang Li, M Neal Guentzel, Guangming Zhong, Bernard P Arulanandam.
Abstract
We previously have shown the efficacy of recombinant (r) chlamydial protease-like activity factor (CPAF) vaccination against hydrosalpinx development following primary genital chlamydial challenge. In this study, we evaluated further the protection induced by rCPAF vaccination against infertility. Following primary challenge, fertility levels were not significantly different between the mock- and CPAF-vaccinated and Chlamydia alone challenged mice. However, following secondary genital chlamydial challenge, mock (PBS) immunized mice displayed a significant reduction of fertility compared to age-matched naïve mice, while mice vaccinated intranasally with rCPAF+CpG displayed significant prevention of infertility. These results suggest that hydrosalpinx may be a reliable indicator of impending infertility, and that rCPAF is a promising candidate to prevent infertility resulting from repeated genital chlamydial infections.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21300093 PMCID: PMC3214972 DOI: 10.1016/j.vaccine.2011.01.074
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641